Brian M. Goff
Brian M. Goff is on the board of Pathways to College Network and Chief Commercial, Global Operations Officer & EVP at Alexion Pharmaceuticals, Inc.
He previously occupied the position of Chief Operating Officer & Director at Neurovance, Inc., Executive Vice President & President-Hematology at Baxalta, Inc., VP, Head-Primary Care & Established medicines at Novartis Pharmaceuticals Corp. and Head-Global Hemophilia Franchise at Baxter Healthcare Corp.
Brian M. Goff received an undergraduate degree from Skidmore College and an MBA from The Wharton School of the University of Pennsylvania.
|12/16/2020||3,261||Derivative/Non-derivative trans. at $157.96 per share.||515,108|
|12/16/2020||18,134||Derivative/Non-derivative trans. at $157.96 per share.||2,864,447|
|12/16/2020||40,677||Award at $0 per share.||0|
|06/08/2020||1,642||Derivative/Non-derivative trans. at $114.61 per share.||188,190|
|03/02/2020||1,401||Derivative/Non-derivative trans. at $90.54 per share.||126,847|
|02/28/2020||10,880||Award at $0 per share.||0|
|02/07/2020||1,594||Derivative/Non-derivative trans. at $102.97 per share.||164,135|
|06/07/2019||1,643||Derivative/Non-derivative trans. at $118.61 per share.||194,877|
|02/28/2019||9,428||Award at $0 per share.||0|
|02/28/2019||670||Derivative/Non-derivative trans. at $132.93 per share.||89,064|
|02/07/2019||1,596||Derivative/Non-derivative trans. at $119.57 per share.||190,834|
|06/08/2018||1,645||Disposition at $118.53 per share.||194,982|
|02/28/2018||8,940||Award at $0 per share.||0|
|02/08/2018||1,651||Disposition at $116.31 per share.||192,028|
|02/06/2018||15,894||Award at $0 per share.||0|
|06/07/2017||14,719||Award at $0 per share.||0|